RESUMO
Aim: To develop, characterize and evaluate an oil/water nanoemulsion with squalene (CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials. Materials & methods: Critical process parameters (CPPs) of CTVad1 were standardized to meet the critical quality attributes (CQAs) of an adjuvant for human use. CTVad1 and the SpiN-CTVad1 vaccine were submitted to physicochemical, stability, in vitro and in vivo studies. Results & conclusion: All CQAs were met in the CTVad1 production process. SpiN- CTVad1 met CQAs and induced high levels of antibodies and specific cellular responses in in vivo studies. These results represented a critical step in the process developed to meet regulatory requirements for the SpiN COVID-19 vaccine clinical trial.
Assuntos
COVID-19 , Vacinas , Humanos , Vacinas contra COVID-19/uso terapêutico , Emulsões/química , COVID-19/prevenção & controle , Adjuvantes Imunológicos/uso terapêutico , Adjuvantes Imunológicos/química , Vacinas/químicaRESUMO
Saponin-based adjuvants are promising adjuvants that enhance both humoral and T-cell-mediated immunity. One of the most used natural products as vaccine adjuvants are Quillaja saponaria bark saponins and its fraction named Quil A®. Despite that, its use has been restricted for human use due to safety issues. As an alternative, our group has been studying the congener species Quillaja brasiliensis saponins and its performance as vaccine adjuvants, which have shown to trigger humoral and cellular immune responses comparable to Quil A® but with milder side effects. Here, we studied a semi purified aqueous extract (AE) and a previously little characterized saponin-enriched fraction (QB-80) from Q. brasiliensis as vaccine adjuvants and an inactivated virus (bovine viral diarrhea virus, BVDV) antigen co-formulated in experimental vaccines in mice model. For the first time, we show the spectra pattern of the Q. brasiliensis saponins by MALDI-TOF, a novel and cost-effective method that could be used to characterize different batches during saponins production. Both AE and QB-80 exhibited noteworthy chemical similarities to Quil A®. In addition, the haemolytic activity and toxicity were assessed, showing that both AE and QB-80 were less toxic than Quil A®. When subcutaneously inoculated in mice, both fractions promoted long-term strong antibody responses encompassing specific IgG1 and IgG2a, enhanced the avidity of IgG antibodies, induced a robust DTH reaction and significantly increased IFN-É£ production in T CD4+ and T CD8+ cells. Furthermore, we have proven herein that AE has the potential to promote dose-sparing, substantially reducing the dose of antigen required for the BVDV vaccines and still eliciting a mixed Th1/Th2 strong immune response. Based on these results, and considering that AE is a raw extract, easier and cheaper to produce than commercially available saponins, this product can be considered as candidate to be escalated from experimental to industrial uses.
Assuntos
Doença das Mucosas por Vírus da Diarreia Viral Bovina/imunologia , Imunidade Celular/imunologia , Extratos Vegetais/imunologia , Quillaja/química , Saponinas/imunologia , Vacinas Virais/imunologia , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/efeitos adversos , Adjuvantes Imunológicos/química , Animais , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Formação de Anticorpos/imunologia , Doença das Mucosas por Vírus da Diarreia Viral Bovina/prevenção & controle , Linfócitos T CD8-Positivos , Bovinos , Vírus da Diarreia Viral Bovina Tipo 1/imunologia , Relação Dose-Resposta Imunológica , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Camundongos , Extratos Vegetais/administração & dosagem , Extratos Vegetais/efeitos adversos , Extratos Vegetais/química , Folhas de Planta/química , Saponinas de Quilaia/administração & dosagem , Saponinas de Quilaia/efeitos adversos , Saponinas de Quilaia/imunologia , Saponinas/química , Saponinas/economia , Saponinas/isolamento & purificação , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Equilíbrio Th1-Th2 , Vacinas Virais/administração & dosagemRESUMO
A trial was conducted to compare the cellular responses in the respiratory tract in intranasal vaccination against caprine Peste des petits ruminant lineage 1 variant virus infection with intramuscular and subcutaneous vaccinations in order to elucidate the mechanism of the protection. Twenty four goats were divided into four equal groups. Group 1 was vaccinated intranasaly, group 2 was vaccinated subcutaneously, and group 3 intramuscularly, while Group 4 was the unvaccinated control group. In each group the vaccinations were carried out once. All goats were challenged intratrachealy with PPR virus at a concentration of 106.5 TCID50 two weeks after vaccination and were euthanised 21 days after the challenge. The bronchoalveolar lavage differential count, bronchial associated lymphoid tissue (BALT) responses were measured using standard techniques. Descriptive Statistics and ANOVA was employed and significance was at p < 0.05. The exposure also resulted into significant increase in the number and size of BALT as well as the number of lymphocytes in BALT. This study showed the mechanism of the protective effect of intranasal vaccination of PPR vaccine observed with the strong mucosal and defensive cellular responses in the respiratory tract observed than the subcutaneous and intramuscular routes.
Se realizó un ensayo para comparar las respuestas celulares en las vías respiratorias después de la vacunación intranasal contra la variante caprina de la infección del virus peste de pequeños rumiantes linaje 1 con vacunas intramusculares y subcutáneas con el fin de dilucidar el mecanismo de protección. Veinticuatro cabras fueron divididas en cuatro grupos iguales. El Grupo 1 fue vacunado por vía intranasal, el grupo 2 vía subcutánea, el grupo 3 vía intramuscular y el grupo 4 control no vacunado. En cada grupo se vacunó sólo una vez. Todas las cabras fueron expuestas al virus peste de pequeños rumiantes por vía intratraqueal a una concentración de 106.5 TCID50 2 semanas después de la vacunación, y fueron sometidos a eutanasia 21 días después. Se midieron el recuento diferencial del lavado broncoalveolar y las respuestas de los tejidos linfoides asociados bronquios (BALT) utilizando técnicas estándar. Los resultados se evaluaron por estadística descriptiva y ANOVA, con una significación p<0,05. La exposición también mostró un aumento significativo en el número y tamaño del BALT, así como el número de linfocitos en este. El estudio mostró que el mecanismo del efecto protector de la vacunación intranasal contra el virus peste de pequeños rumiantes posee una respuesta mucosa y celular defensiva en el tracto respiratorio mayor que la observada por vacunación vía subcutánea e intramuscular.